Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NeuronesXPAR:NRO +2.58%98 Earnings Yield (Joel Greenblatt) % is 10.75% as of Dec. 2025, which is 6% above its 10-year median of 10.18. GuruFocus rates XPAR:NRO with a GF Score™ of 98/100 and a GF Value™ of €50.68 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 2,916 Software companies, Neurones ranks better than 86.04% on this metric.
Neurones's Enterprise Value for the quarter that ended in Dec. 2025 was €807.8 Mil.
Neurones's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €86.8 Mil. Neurones's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2025 was 10.75%.
The historical rank and industry rank for Neurones's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
XPAR:NRO'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.72 Med: 10.18 Max: 20.94
Current: 13.13
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Neurones was 20.94%. The lowest was 7.72%. And the median was 10.18%.
XPAR:NRO's Earnings Yield (Joel Greenblatt) % is ranked better than 86.04% of 2916
companies
in the Software industry
Industry Median: 2.085
vs XPAR:NRO: 13.13
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Neurones's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2025 was 14.78%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Neurones Earnings Yield (Joel Greenblatt) % Related Terms
Neurones Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Neurones's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Information Technology Services subindustry, Neurones's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neurones Earnings Yield (Joel Greenblatt) % vs Software Industry
For the Software industry and Technology sector, Neurones's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Neurones's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Neuroness Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 10.75% mean?
Neurones (XPAR:NRO) has a Earnings Yield (Joel Greenblatt) % of 10.75% as of Dec. 2025. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Neurones and its competitors. This is near median its historical median of 10.18. Over the past decade, Neurones' Earnings Yield (Joel Greenblatt) % has ranged from 7.72 to 20.94. According to the industry distribution chart, Neurones ranks #407 out of 2916 companies in the Software industry, placing it in the top 14%.
Is Neurones' Earnings Yield (Joel Greenblatt) % too high?
Neurones' current Earnings Yield (Joel Greenblatt) % of 10.75% is near median its 10-year median of 10.18. Over the past 10 years, this metric has ranged from a low of 7.72 to a high of 20.94. The Software industry median Earnings Yield (Joel Greenblatt) % is 2.09. Neurones' value of 10.75% is 415.6% above this industry median. Based on the distribution chart, Neurones ranks #407 out of 2916 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Neurones has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' Earnings Yield (Joel Greenblatt) % compare to IBM and ACN?
According to the Software industry distribution chart, Neurones ranks #407 out of 2916 companies for Earnings Yield (Joel Greenblatt) %. This places Neurones in the top 14% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 2.09. Neurones' value of 10.75% is 415.6% above this benchmark. Historically, Neurones' own Earnings Yield (Joel Greenblatt) % has ranged from 7.72 to 20.94 over the past decade. While the company's 10-year median is 10.18 vs. the industry median of 2.09, Neurones has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Software company?
The median Earnings Yield (Joel Greenblatt) % among Software companies is 2.09, based on 2,916 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neurones's current Earnings Yield (Joel Greenblatt) % of 10.75% is 415.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Neurones and its competitors. For the Software industry, the median Earnings Yield (Joel Greenblatt) % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neurones's current Earnings Yield (Joel Greenblatt) % is 10.75%, which is near median its own 10-year median of 10.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.68, compared to a current price of €37.75 — trading 25.5% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 10.75%, which is near median its 10-year median of 10.18 and 415.6% above the Software industry median of 2.09. Neurones' overall GF Score™ is 98/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Earnings Yield (Joel Greenblatt) % is 10.75% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Neurones (XPAR:NRO) Overvalued in 2026?
Based on GuruFocus' analysis, Neurones stock appears to be undervalued.
The current stock price of €37.75 is trading 25.5% below its estimated GF Value™ of €50.68.
GuruFocus considers Neurones to be Modestly Undervalued.
Key valuation signals for XPAR:NRO:
Earnings Yield (Joel Greenblatt) %: 10.75% (near median its 10-year median of 10.18)
GF Value™: €50.68 vs. price of €37.75 (25.5% below fair value)
Industry Position: 415.6% above the Software median (#407 of 2916)
No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
98GF Score
Get the complete analysis for XPAR:NRO
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:NRO has been successfully added to your 
